Suchergebnisse - "Guglielmetti, Lorenzo"

Bedaquiline for the treatment of multidrug-resistant tuberculosis: another missed opportunity? von Guglielmetti, Lorenzo

Weitere Angaben

Optimal management of drug-resistant tuberculosis: Can India lead the way? von Masini, Tiziana, Furin, Jennifer, Udwadia, Zarir, Guglielmetti, Lorenzo

Volltext

Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis von Guglielmetti, Lorenzo, Jaspard, Marie, Le Dû, Damien, Lachâtre, Marie, Marigot-Outtandy, Dhiba, Bernard, Christine, Veziris, Nicolas, Robert, Jérôme, Yazdanpanah, Yazdan, Caumes, Eric, Fréchet-Jachym, Mathilde

“… Bedaquiline, a recently approved drug for the treatment of multidrug-resistant tuberculosis (MDR-TB), is recommended for a duration of 24 weeks. There are …”
Weitere Angaben

Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis von Mbuagbaw, Lawrence, Guglielmetti, Lorenzo, Hewison, Catherine, Bakare, Nyasha, Bastard, Mathieu, Caumes, Eric, Fréchet-Jachym, Mathilde, Robert, Jérôme, Veziris, Nicolas, Khachatryan, Naira, Kotrikadze, Tinatin, Hayrapetyan, Armen, Avaliani, Zaza, Schünemann, Holger J., Lienhardt, Christian

“… Bedaquiline is recommended by the World Health Organization for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis …”
Volltext

Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors von Veziris, Nicolas, Bernard, Christine, Guglielmetti, Lorenzo, Le Du, Damien, Marigot-Outtandy, Dhiba, Jaspard, Marie, Caumes, Eric, Lerat, Isabelle, Rioux, Christophe, Yazdanpanah, Yazdan, Tiotiu, Angelica, Lemaitre, Nadine, Brossier, Florence, Jarlier, Vincent, Robert, Jerome, Sougakoff, Wladimir, Aubry, Alexandra

Weitere Angaben

Preventive Therapy for Contacts of Drug-Resistant Tuberculosis von Kherabi, Yousra, Tunesi, Simone, Kay, Alexander, Guglielmetti, Lorenzo

“… Preventing the progression of a drug-resistant tuberculosis (DR-TB) infection to disease is an important pillar of the DR-TB elimination strategy …”
Volltext

Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019 von Kherabi, Yousra, Fréchet-Jachym, Mathilde, Rioux, Christophe, Yazdanpanah, Yazdan, Méchaï, Frédéric, Pourcher, Valérie, Robert, Jérôme, Guglielmetti, Lorenzo

“… Definitions of resistance in multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB) have been updated. Pre-XDR TB, …”
Volltext

Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment von Gerussi, Valentina, Petersen, Tania, Bonnet, Isabelle, Aubry, Alexandra, Bachir, Marwa, Gyde, Esther, Morel, Florence, Poignon, Corentin, Rached, Brigitte, Pourcher, Valérie, Rioux, Christophe, Vallois, Dorothée, Veziris, Nicolas, Robert, Jérôme, Guglielmetti, Lorenzo

“… High-dose isoniazid is recommended to treat multidrug-resistant tuberculosis (MDR TB). Among 958 MDR TB isolates identified in France during 2008-2022, 93.1% …”
Volltext

Communicable Episode 20: Tuberculosis today von Hostettler, Kathryn, Guglielmetti, Lorenzo, Konstantynovska, Olha, Narayanan, Navaneeth, Huttner, Angela

Volltext

Treatment for COVID-19—a cohort study from Northern Italy von Guglielmetti, Lorenzo, Aschieri, Daniela, Kontsevaya, Irina, Calabrese, Francesco, Donisi, Alessandra, Faggi, Alberto, Ferrante, Patrizia, Fronti, Elisa, Gerna, Laura, Leoni, Maria Cristina, Paolillo, Franco, Ratti, Giovanna, Ruggieri, Alessandro, Sacchini, Daria, Scotti, Marta, Valdatta, Caterina, Stabile, Marco, Taliani, Gloria, Codeluppi, Mauro

“… Multicentre, retrospective cohort study with multivariable Cox proportional-hazards modelling and survival-time inverse-probability-weighting, evaluating the …”
Volltext

Safety and efficacy of exposure to bedaquiline-delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia von Guglielmetti, Lorenzo, Barkane, Linda, Le Dû, Damien, Marigot-Outtandy, Dhiba, Robert, Jérôme, Veziris, Nicolas, Yazdanpanah, Yazdan, Kuksa, Liga, Caumes, Eric, Fréchet-Jachym, Mathilde

Weitere Angaben

Impact of the COVID-19 pandemic on the real-world diagnostic infrastructure for tuberculosis—An ESGMYC collaborative study von Paulowski, Laura, Filip, Roxana, Jankovic Makek, Mateja, Guglielmetti, Lorenzo, Goletti, Delia, van Ingen, Jakko, Kranzer, Katharina, Maurer, Florian P.

“… We determined the impact of the COVID-19 pandemic on mycobacterial diagnostic services. 40 laboratories from 22 countries completed an online questionnaire …”
Volltext

A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2025 Update for Clinicians and Scientists von Lange, Christoph, Bothamley, Graham, Günther, Gunar, Guglielmetti, Lorenzo, Kontsevaya, Irina, Kuksa, Liga, Lange, Berit, Lorent, Natalie, Saluzzo, Francesca, Sester, Martina, Tebruegge, Marc, Tunesi, Simone, Tweed, Conor

“… Background: In the field of tuberculosis and non-tuberculous mycobacterial (NTM) disease we are looking back on an exciting year 2024 with more than 10,000 …”
Volltext

Shortened multidrug-resistant tuberculosis treatment in settings with a high prevalence of ofloxacin resistance von Guglielmetti, Lorenzo, Varaine, Francis, Huerga, Helena, Bonnet, Maryline, Rich, Michael L, Mitnick, Carole D

Weitere Angaben

Severe COVID-19 pneumonia in Piacenza, Italy — A cohort study of the first pandemic wave von Guglielmetti, Lorenzo, Kontsevaya, Irina, Leoni, Maria C., Ferrante, Patrizia, Fronti, Elisa, Gerna, Laura, Valdatta, Caterina, Donisi, Alessandra, Faggi, Alberto, Paolillo, Franco, Ratti, Giovanna, Ruggieri, Alessandro, Scotti, Marta, Sacchini, Daria, Taliani, Gloria, Codeluppi, Mauro

“… Piacenza is the closest city to the first coronavirus disease 2019 (COVID-19) cluster in Italy and has the highest national COVID-19 death rates per …”
Volltext

Case Report: B Lymphocyte Disorders Under COVID-19 Inflammatory Pressure von Taliani, Gloria, Follini, Elena, Guglielmetti, Lorenzo, Bernuzzi, Patrizia, Faggi, Alberto, Ferrante, Patrizia, Fronti, Elisa, Gerna, Laura, Leoni, Maria Cristina, Paolillo, Franco, Ratti, Giovanna, Ruggieri, Alessandro, Valdatta, Caterina, Donisi, Alessandra, Zangrandi, Adriano, Pochintesta, Lara, Moroni, Carlo, Sacchini, Daria, Vallisa, Daniele, Codeluppi, Mauro

“… Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infects humans through the angiotensin converting enzyme-2 (ACE-2) receptor expressed on many …”
Volltext

Management of Tuberculosis: Are the Practices Homogeneous in High-Income Countries? von Méchaï, Frédéric, Cordel, Hugues, Guglielmetti, Lorenzo, Aubry, Alexandra, Jankovic, Mateja, Viveiros, Miguel, Santin, Miguel, Goletti, Delia, Cambau, Emmanuelle

“… To evaluate and compare practices regarding the diagnosis, isolation measures, and treatment of tuberculosis (TB) in high-income countries and mainly in …”
Volltext

Cardiac safety of multidrug-resistant tuberculosis treatment: moving towards individualised monitoring von Hewison, Catherine, Guglielmetti, Lorenzo

“… A heart rate-corrected QT interval (QTc) of 500 ms or more increases the risk of potentially fatal ventricular arrhythmias, including torsade de pointes.2 …”
Volltext

The coming-of-age of bedaquiline: a tale with an open ending von Guglielmetti, Lorenzo, Varaine, Francis

Weitere Angaben

COVID-19 in Italy: passing through bitter waters von Guglielmetti, Lorenzo, Chiesi, Sheila

Weitere Angaben